Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01747863 : Prospective Research in Infants With Mild Encephalopathy
PhaseN/A
AgesMin: N/A Max: 6 Hours
Eligibility
Inclusion Criteria:

- Infants with birth weight > or = 1800g and gestational age > or = 36 weeks AND

- Admission to neonatal intensive care unit (NICU) for possible hypothermia at < or =
6hr of life

Exclusion Criteria:

- Infants with normal neurological evaluation

- Major congenital abnormalities

- Refusal of informed consent

- Infants who receive passive or active cooling prior to the NICU admission

- Infants that develop seizures or moderate/severe NE within the first 24 hr of life
and are initiated on therapeutic hypothermia after 6 hr of life.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01747863      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740